SEC Form 5/A · accession 0001388410-17-000009
PARALLAX HEALTH SCIENCES, INC. · PRLX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 5/A). It replaces an earlier filing for the same period.
Reporting owner
Jorn Gorlach
Director · 10% Owner
Period of report
Dec 31, 2012
Accepted (ET)
Feb 2, 2017 · 6:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388410
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF2 | Dec 6, 2012 | J | 4,578,747 | $0.001 | A | 4,578,747 | D | |
| COMMON STOCK | Dec 6, 2012 | J | 4,960,310 | $0.001 | A | 9,539,057 | I | By Avantgarde LLC |
| COMMON STOCK | Dec 6, 2012 | J | 9,359,057 | $0.001 | A | 18,898,114 | I | By Montecito BioSciences Ltd. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares issued/acquired pursuant to share exchange agreement dated November 1, 2012 between Endeavor Power Corporation and Parallax Diagnostics, Inc.
- F2Joint ownership with spouse
Remarks
ORIGINAL FORM 5 ERRONEOUSLY REPORTED SHARES HELD IN IRREVOCABLE TRUSTS. REPORTING PERSON HAS NO CONTROL OVER TRUSTS' HOLDINGS. THIS FILING CORRECTS TOTAL NUMBER OF COMMON SHARES HELD DIRECTLY/INDIRECTLY BY REPORTING PERSON AT 12/31/2012.